Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

Integra Lifesciences Reports Clinical Outcomes Of PriMatrix Dermal Repair Scaffold For Mgmt. Of Diabetic Foot Ulcers: With 100+ Patients Per Treatment Group, Showed ‘in most cases, one application of PriMatrix plus standard of care (SOC) healed 60% of…

By Benzinga Newsdesk
Today, 6:58 PM
Integra LifeSciences Holding Corporation (NASDAQ:IART), a leading global medical technology company, today announced positive clinical outcomes for PriMatrix® Dermal Repair Scaffold for the management of hard to heal

IART